Olympiad Research’s Aveanna Healthcare AVAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$125K Sell
14,603
-9,215
-39% -$65K 0.26% 111
2026
Q1
$153K Buy
23,818
+6,247
+36% +$48.3K 0.47% 63
2025
Q4
$144K Sell
17,571
-14,050
-44% -$127K 0.38% 84
2025
Q3
$280K Buy
31,621
+2,200
+7% +$13.9K 0.39% 92
2025
Q2
$154K Buy
29,421
+13,385
+83% +$68K 0.25% 152
2025
Q1
$86.9K Buy
+16,036
New +$75.7K 0.1% 221

Other funds holding AVAH

Olympiad Research's AVAH Position: Q2 2026 in Review

Olympiad Research reduced its Aveanna Healthcare (AVAH) stake by 39% in Q2 2026, selling an estimated $65K and leaving 14,603 shares worth $125K. The position accounts for 0.26% of the portfolio, ranked #111.

Olympiad Research first reported a position in AVAH in Q1 2025 and has held it in 6 quarters since. The position peaked at $280K in Q3 2025. 215 funds tracked by Wall St. Rank hold AVAH as of Q2 2026.

  • Olympiad Research held 14,603 shares of Aveanna Healthcare worth $125K as of Q2 2026.
  • Olympiad Research sold 9,215 Aveanna Healthcare shares in Q2 2026, an estimated $65K.
  • Aveanna Healthcare made up 0.26% of Olympiad Research's portfolio in Q2 2026, its #111 holding.
  • Olympiad Research first reported a position in Aveanna Healthcare in Q1 2025 and has held it in 6 quarters since.
  • Olympiad Research's Aveanna Healthcare position peaked at $280K in Q3 2025.
  • 215 funds tracked by Wall St. Rank held Aveanna Healthcare as of Q2 2026.

Based on Olympiad Research's 13F filing for Q2 2026, filed 24 Jul 2026.